Developer docs
API playgroundTry for free, no card

Search company profiles

Generic Health

Full company profile

uuid0022cm6

Namestring
Generic Health
Legal namestring
Generic Health Pty Ltd
Company typeenum
Private
Founded yearint
2004
Descriptiontext

Generic Health Pty Ltd, operating from Box Hill, Victoria and now trading as Lupin AU, is a wholly-owned subsidiary of India's Lupin Limited — one of the world's top ten generic pharmaceutical companies — and is a leading Australia-and-New Zealand-based supplier of generic prescription medicines, specialty injectable products, and over-the-counter (OTC) consumer health brands. The company serves three primary commercial segments: public and private hospitals (supplied via dedicated hospital account managers with injectable and oral generic products), community pharmacies (supplied via pharmacy chains and independents with PBS-listed generic prescriptions and OTC lines), and end consumers (via retail pharmacy channels for OTC lines). Its product ecosystem is organized around four brands: Generic Health (specialty injectables and oral generics), Pharmacy Action (OTC value range launched 2013), Goanna (heritage therapeutic oils and creams, 100+ year Australian brand, marketing rights acquired 2011), and Minoxidil (topical OTC hair-loss treatment).

The company's technology base is pharmaceutical formulation development and generic-drug manufacturing, with quality standards meeting Australian Therapeutic Goods Administration (TGA) requirements equivalent to originator brands. Its go-to-market is a B2B distribution-led model: enterprise field sales to hospitals, channel relationships with pharmacy chains, and licensed out-licensing/in-licensing operations — generating revenue through unit sales of PBS-reimbursed generics, OTC consumer health products, hospital injectables, and licensing royalties. Headcount sits in the 51-100 range and the business self-reports as one of the fastest-growing pharmaceutical companies in Australia, with approximately 100% revenue growth over the trailing twelve months.

Generic Health's growth has been built through a serial acquisition strategy: Bellwether Pharma (2007) for early generic supply, Max Pharma (2009) for specialty hospital generics, Goanna brand rights (2011), the controlling and then full takeover by Lupin (2008 majority, 2011 100%, 2012 formal acquisition), Horizon Hospital Healthcare injectable products (2019), and Southern Cross Pharma (2021). The company now operates as the Australian/New Zealand commercial arm of Lupin Group, leveraging global generics scale, sourcing, and pipeline depth while maintaining a portfolio-led Australian brand identity across prescription, hospital, and OTC channels.

Short descriptiontext

Generic Health Pty Ltd (trading as Lupin AU), a wholly-owned subsidiary of India's Lupin Limited, supplies generic prescription medicines, specialty injectable products, and over-the-counter brands (Pharmacy Action, Goanna, Minoxidil) to community pharmacies, public and private hospitals, and consumers across Australia and New Zealand.

Operating statusenum
Operating
Ownership categoryenum
Headcount rangeband
11–50
akta.pro rankint
HeadquartersBox Hill, Australia
HQ citystring
Box Hill
HQ countrystring
Australia
HQ regionstring
Oceania
Markets served

Serves global market

Offices1 record

Each record includes

City, Country, Type, Description, Source

Keyword5 values
generic pharmaceuticals, over-the-counter medicines, specialty injectables, hospital generics, prescription generics
Industry4 codes
PRIMARYHLAIABAA
Small-Molecule Generics (Branded/Unbranded)
SECONDARYHLAIABAC
Sterile Injectable Generics
SECONDARYHLAIAAAB
Specialty Care Pharmaceuticals
Healthcare & Life Sciences/Pharmaceuticals/Branded (Innovator) Pharmaceuticals
SECONDARYHLAIAJAB
Specialty Pharmaceutical Distributors
Healthcare & Life Sciences/Pharmaceuticals/Pharmaceutical Distribution & Wholesaling
NAICS code3 codes
  • Pharmaceutical and Medicine Manufacturing32541
  • Pharmaceutical Preparation Manufacturing325412
  • Drugs and Druggists' Sundries Merchant Wholesalers4242
SIC code2 codes
  • Pharmaceutical Preparations2834
  • Wholesale-Drugs, Proprietaries & Druggists' Sundries5122
Product category
Generic Pharmaceuticals
GTM motion2 records

Each record includes

Type, Description, Source

Revenue model4 records
1Prescription Generic Medicines
TypeOne Time License
Description

Generic prescription pharmaceuticals sold to patients through pharmacies, reimbursed under the Pharmaceutical Benefits Schedule (PBS) in Australia.

generichealth.com.au
2Over-the-Counter Products
TypeOne Time License
Description

OTC pharmaceutical products sold directly to consumers through pharmacies, including the Pharmacy Action brand range.

generichealth.com.au
3Hospital Injectable Products
TypeOne Time License
Description

Specialty injectable products supplied to public and private hospitals across Australia.

generichealth.com.au
4Licensing
TypeLicensing Royalties
Description

Out-licensing and in-licensing of pharmaceutical molecules and products to/from other pharmaceutical companies.

generichealth.com.au
Marketing channels4 records

Each record includes

Title, Type, Stage, Description, Source

Distribution channels3 records

Each record includes

Title, Type, Scope, Target buyer, Description, Source

Cost components6 values
Supply Chain, Operations, Personnel, Technology or R&D, Marketing or Sales, Others
GTM typeB2B
B2B
Offering typeHardware or Manufacturing
Hardware or Manufacturing
Brand1 of 4 records shown
1Generic Health
Description

Speciality injectables and oral products, and generic prescription products available to patients in local pharmacies.

generichealth.com.au
+3 more records
Core offering1 text field

Generic Health manufactures and supplies high-quality generic prescription medicines, specialty injectable products, and over-the-counter medicines to pharmacies and hospitals across Australia and New Zealand. The portfolio is sold under the Generic Health, Pharmacy Action, Goanna, and Minoxidil brands, with supply into public and private hospitals via dedicated account managers and into community pharmacies through distribution partnerships. The company also conducts in-licensing and out-licensing of pharmaceutical molecules and products with other pharmaceutical firms.

Differentiator
Functional benefit
Problem solved
Quantifiable outcome1 of 2 values shown
  • Nearly 100% revenue growth in past 12 months
+1 more record
Product overview1 text field

Generic Health is a pharmaceutical company offering a comprehensive portfolio of generic prescription medicines, specialty injectable products, and over-the-counter medicines. The company's product ecosystem includes the core Generic Health brand (specialty injectables and prescription generics), Pharmacy Action (OTC range), Goanna (therapeutic oils and creams for pain relief), and Minoxidil (hair loss treatment). Hospital-specific products are also provided. The company focuses on launching off-patent molecules at PBS listing dates and maintains a commitment to quality standards equivalent to original brands while delivering cost savings to pharmacies, hospitals, and consumers.

Product and service5 records
1Generic Health Brand
CategoryGeneric prescription pharmaceuticals (injectable and oral)
Description

Specialty injectables and oral generic prescription products made available to patients through local pharmacies and supplied to hospitals; products and manufacturing facilities meet the same strict standards as the original brand, offered at competitive value.

2Pharmacy Action
CategoryOver-the-counter (OTC) medicines
Description

Comprehensive range of over-the-counter (OTC) pharmaceutical products available in pharmacies across Australia, positioned as a cost-effective alternative to original brands while maintaining comparable quality, safety, and efficacy standards.

3Goanna
CategoryTherapeutic OTC topicals (analgesic rubs/creams)
Description

Premium therapeutic oils and creams trusted by Australians for over 100 years, combining Australian ingredients with modern pharmaceutical research to provide temporary relief from muscular aches and pains and mild arthritis symptoms.

4Minoxidil
CategoryOver-the-counter (OTC) hair loss treatment
Description

Over-the-counter topical minoxidil (5%) hair loss treatment for men and women in Australia for androgenetic alopecia (male and female pattern hair loss), promoting hair growth via improved blood flow and activation of biological pathways in hair follicles.

5Hospital Portfolio
CategoryHospital generics (injectable and oral prescription products)
Description

Prescription products in both injectable and oral dosage forms supplied to public and private hospitals across Australia, meeting the strict quality standards of Generic Health products while offering excellent value to hospital formularies.

Scale indicator4 records

Each record includes

Type, Value, Description, Source

Partnership6 partners
Strategic tierMinorTypeStrategic or Co-development PartnerAnnounced on2021-01-01
Description

Acquired Southern Cross Pharma Pty Ltd in 2021 as part of ongoing expansion strategy.

Strategic tierMinorTypeStrategic or Co-development PartnerAnnounced on2019-01-01
Description

Acquired a range of injectable products from Horizon Hospital Healthcare in 2019, expanding the hospital portfolio.

Strategic tierCoreTypeStrategic or Co-development PartnerAnnounced on2011-01-01
Description

Acquired marketing rights to the Goanna brand of therapeutic creams, rubs and oils in 2011, a trusted Australian brand with over 100 years of heritage.

4Max Pharma Pty Ltd
Strategic tierCoreTypeStrategic or Co-development PartnerAnnounced on2009-01-01
Description

Acquired in 2009, Max Pharma expanded Generic Health's product portfolio to include specialty hospital generics.

generichealth.com.au
5Bellwether Pharma Ltd
Strategic tierCoreTypeStrategic or Co-development PartnerAnnounced on2007-01-01
Description

Acquired in 2007, Bellwether Pharma was a supplier of quality generic pharmaceuticals that strengthened Generic Health's early business foundations.

generichealth.com.au
Strategic tierMinorTypeOthers
Description

Became a member of APCO in 2020, committed to working towards achieving the 2025 National Packaging Targets and ensuring packaging materials are reusable, renewable, or recyclable.

Recent move6 records

Each record includes

Date, Type, Title, Description, Source

Expansion highlight5 records

Each record includes

Type, Description

Peers10 records
TypeDirect peer
Description

Australian generic pharmaceutical subsidiary of Viatris, one of the largest suppliers of prescription generics in Australia. Most direct head-to-head competitor for Generic Health in Australian PBS-reimbursed prescription generics and pharmacy distribution.

TypeDirect peer
Description

Canadian-headquartered generic pharmaceutical manufacturer with significant Australian operations. Competes directly with Generic Health in the Australian generic prescription market across multiple therapeutic categories distributed through the same pharmacy and hospital channels.

TypeDirect peer
Description

Australian specialty pharmaceutical company focused on branded and generic prescription products. Directly comparable as an ANZ-headquartered competitor with overlapping generics and specialty product portfolios targeting similar pharmacy and hospital customers.

TypeRegional player
Description

Australian privately-held pharmaceutical company specializing in dermatology and OTC skincare products. Comparable in the ANZ OTC consumer health segment where Generic Health's Pharmacy Action and Goanna brands compete.

TypeRegional player
Description

Australia and New Zealand-headquartered specialty pharmaceutical company with both OTC and prescription products. Overlaps with Generic Health's OTC portfolio (Pharmacy Action, Goanna) and operates in the same ANZ geographies.

TypeDirect peer
Description

Australia's largest generic pharmaceutical company by volume, formed via acquisition of multiple local generic businesses. Directly competes with Generic Health in prescription generics and OTC categories across Australian community pharmacy channels.

TypeBroad incumbent
Description

Global pharmaceutical company formed from Mylan-Upjohn combination with substantial generic and specialty portfolio. Competes with Generic Health in Australian prescription generics, specialty injectables, and hospital channel.

TypeBroad incumbent
Description

World's largest generic pharmaceutical manufacturer with operations across most major markets including Australia. Competes broadly with Generic Health across generic prescription categories and specialty products.

9Sandoz (Novartis)
TypeBroad incumbent
Description

Global generic and biosimilar division of Novartis, one of the largest generic players worldwide. Operates in the Australian generic prescription market as a broad incumbent competing with Generic Health across multiple molecule categories.

TypeBroad incumbent
Description

Australian subsidiary of Indian global generic major Cipla. Competes with Generic Health in Australian prescription generics and respiratory/injectable categories, backed by similar parent-company scale economics.

Market position
Strengths4 records

Each record includes

Headline, Details, Source

Weaknesses4 records

Each record includes

Headline, Details, Source

Competitive moat5 records

Each record includes

Type, Details

Key risks6 records

Each record includes

Headline, Details, Source

Key highlights7 records

Each record includes

Headline, Details, Source

Customer concentration

Classification, Details

Named customers2 records

Each record includes

Name, Industry, Type, Use case, Source, UUID

Segment4 records

Each record includes

Title, Type, Primary, Description, Pain point addressed, Use case, Source

Ideal customer profile3 records

Each record includes

Profile, Firmographic size, Sales motion, Sales cycle length, Buying structure, Purchase trigger, Buyer persona, Geography, Industry vertical, Primary use case, Description, Pain points, Evidence proof points, Target buyer

Technology focused
No
API detail
Has APIbool
No

Docs URL, Description

AI maturity
App detail

Has app

Core technology
Revenue estimate
Valuation estimate
Number of profiles
Profiles1 record

Each record includes

Name, Designation, Designation category, Overview, Profile commentary, Source

No data
No data
Funding overview

Funding stage, Last funding date, Total funding USD

Funding rounds

Each record includes

Round, Amount USD, Date, Pre money valuation, Total investors, Investors, News

Investors

Each record includes

Name, Type, Date of entry, Rounds participated, Website

Funding detail is available on the Subscription and Enterprise plan.Contact sales →

M&A

Each record includes

Name, Acquisition type, Announced date, Completed date, Status, Website, News

Investment

Each record includes

Name, Round, Announced date, Lead investor, Website, News

M&A and investment is available on the Subscription and Enterprise plan.Contact sales →

Generic Health

Generic Pharmaceuticalsgenerichealth.com.au

Generic Health Pty Ltd (trading as Lupin AU), a wholly-owned subsidiary of India's Lupin Limited, supplies generic prescription medicines, specialty injectable products, and over-the-counter brands (Pharmacy Action, Goanna, Minoxidil) to community pharmacies, public and private hospitals, and consumers across Australia and New Zealand.

What Generic Health does

Generic Health Pty Ltd, operating from Box Hill, Victoria and now trading as Lupin AU, is a wholly-owned subsidiary of India's Lupin Limited — one of the world's top ten generic pharmaceutical companies — and is a leading Australia-and-New Zealand-based supplier of generic prescription medicines, specialty injectable products, and over-the-counter (OTC) consumer health brands. The company serves three primary commercial segments: public and private hospitals (supplied via dedicated hospital account managers with injectable and oral generic products), community pharmacies (supplied via pharmacy chains and independents with PBS-listed generic prescriptions and OTC lines), and end consumers (via retail pharmacy channels for OTC lines). Its product ecosystem is organized around four brands: Generic Health (specialty injectables and oral generics), Pharmacy Action (OTC value range launched 2013), Goanna (heritage therapeutic oils and creams, 100+ year Australian brand, marketing rights acquired 2011), and Minoxidil (topical OTC hair-loss treatment).

The company's technology base is pharmaceutical formulation development and generic-drug manufacturing, with quality standards meeting Australian Therapeutic Goods Administration (TGA) requirements equivalent to originator brands. Its go-to-market is a B2B distribution-led model: enterprise field sales to hospitals, channel relationships with pharmacy chains, and licensed out-licensing/in-licensing operations — generating revenue through unit sales of PBS-reimbursed generics, OTC consumer health products, hospital injectables, and licensing royalties. Headcount sits in the 51-100 range and the business self-reports as one of the fastest-growing pharmaceutical companies in Australia, with approximately 100% revenue growth over the trailing twelve months.

Generic Health's growth has been built through a serial acquisition strategy: Bellwether Pharma (2007) for early generic supply, Max Pharma (2009) for specialty hospital generics, Goanna brand rights (2011), the controlling and then full takeover by Lupin (2008 majority, 2011 100%, 2012 formal acquisition), Horizon Hospital Healthcare injectable products (2019), and Southern Cross Pharma (2021). The company now operates as the Australian/New Zealand commercial arm of Lupin Group, leveraging global generics scale, sourcing, and pipeline depth while maintaining a portfolio-led Australian brand identity across prescription, hospital, and OTC channels.

Generic Health firmographics

Firmographics
Name
Generic Health
Legal name
Generic Health Pty Ltd
Website
https://generichealth.com.au
Company type
Private
Founded year
2004
Operating status
Operating
Headcount range
11–50 employees
Short description
Generic Health Pty Ltd (trading as Lupin AU), a wholly-owned subsidiary of India's Lupin Limited, supplies generic prescription medicines, specialty injectable products, and over-the-counter brands (Pharmacy Action, Goanna, Minoxidil) to community pharmacies, public and private hospitals, and consumers across Australia and New Zealand.
Ownership category
akta.pro rank

Generic Health industry classification

Industry
Product category
Generic Pharmaceuticals
NAICS
Pharmaceutical and Medicine Manufacturing (32541), Pharmaceutical Preparation Manufacturing (325412), Drugs and Druggists' Sundries Merchant Wholesalers (4242)
SIC
Pharmaceutical Preparations (2834), Wholesale-Drugs, Proprietaries & Druggists' Sundries (5122)
akta.pro industry
PRIMARYHLAIABAA
Small-Molecule Generics (Branded/Unbranded)
SECONDARYHLAIABAC
Sterile Injectable Generics
SECONDARYHLAIAAAB
Specialty Care Pharmaceuticals
Healthcare & Life Sciences/Pharmaceuticals/Branded (Innovator) Pharmaceuticals
SECONDARYHLAIAJAB
Specialty Pharmaceutical Distributors
Healthcare & Life Sciences/Pharmaceuticals/Pharmaceutical Distribution & Wholesaling

Keywords

  • Generic pharmaceuticals
  • Over-the-counter medicines
  • Specialty injectables
  • Hospital generics
  • Prescription generics

Where Generic Health is headquartered

Location

Headquarters

HQ city
Box Hill
HQ country
Australia
HQ region
Oceania

Offices1 record

Markets served

Generic Health business model

Business model
GTM type
B2B
Offering type
Hardware or Manufacturing
Cost components
Supply Chain, Operations, Personnel, Technology or R&D, Marketing or Sales, Others

Revenue model

  1. Prescription Generic Medicines: Generic prescription pharmaceuticals sold to patients through pharmacies, reimbursed under the Pharmaceutical Benefits Schedule (PBS) in Australia.
  2. Over-the-Counter Products: OTC pharmaceutical products sold directly to consumers through pharmacies, including the Pharmacy Action brand range.
  3. Hospital Injectable Products: Specialty injectable products supplied to public and private hospitals across Australia.
  4. Licensing: Out-licensing and in-licensing of pharmaceutical molecules and products to/from other pharmaceutical companies.

Go-to-market motion2 records

Distribution channels3 records

Marketing channels4 records

Generic Health product offering

Product offering

Core offering

Generic Health manufactures and supplies high-quality generic prescription medicines, specialty injectable products, and over-the-counter medicines to pharmacies and hospitals across Australia and New Zealand. The portfolio is sold under the Generic Health, Pharmacy Action, Goanna, and Minoxidil brands, with supply into public and private hospitals via dedicated account managers and into community pharmacies through distribution partnerships. The company also conducts in-licensing and out-licensing of pharmaceutical molecules and products with other pharmaceutical firms.

Product overview

Generic Health is a pharmaceutical company offering a comprehensive portfolio of generic prescription medicines, specialty injectable products, and over-the-counter medicines. The company's product ecosystem includes the core Generic Health brand (specialty injectables and prescription generics), Pharmacy Action (OTC range), Goanna (therapeutic oils and creams for pain relief), and Minoxidil (hair loss treatment). Hospital-specific products are also provided. The company focuses on launching off-patent molecules at PBS listing dates and maintains a commitment to quality standards equivalent to original brands while delivering cost savings to pharmacies, hospitals, and consumers.

Differentiator

Problem solved

Functional benefit

Brands

  • Generic Health: Speciality injectables and oral products, and generic prescription products available to patients in local pharmacies.
  • Pharmacy Action
  • Goanna
  • Minoxidil

Products and services

  • Generic Health Brand Specialty injectables and oral generic prescription products made available to patients through local pharmacies and supplied to hospitals; products and manufacturing facilities meet the same strict standards as the original brand, offered at competitive value.
  • Pharmacy Action Comprehensive range of over-the-counter (OTC) pharmaceutical products available in pharmacies across Australia, positioned as a cost-effective alternative to original brands while maintaining comparable quality, safety, and efficacy standards.
  • Goanna Premium therapeutic oils and creams trusted by Australians for over 100 years, combining Australian ingredients with modern pharmaceutical research to provide temporary relief from muscular aches and pains and mild arthritis symptoms.
  • Minoxidil Over-the-counter topical minoxidil (5%) hair loss treatment for men and women in Australia for androgenetic alopecia (male and female pattern hair loss), promoting hair growth via improved blood flow and activation of biological pathways in hair follicles.
  • Hospital Portfolio Prescription products in both injectable and oral dosage forms supplied to public and private hospitals across Australia, meeting the strict quality standards of Generic Health products while offering excellent value to hospital formularies.

Quantifiable outcome

  • Nearly 100% revenue growth in past 12 months
  • +1 more outcomes

Companies that use Generic Health

Customer profile

Named customers2 records

Segments4 records

Ideal customer profiles3 records

Generic Health technology and API

Technology

Technology focussed No

API detail

Has API
No
API docs
API detail

Core technology

AI maturity

App detail

Generic Health partnerships and signals

Strategic signal

Partnerships

Six partnerships are on record, tiered minor and core.

  • Southern Cross Pharma Pty LtdminorStrategic or Co-development Partner · 1 January 2021Acquired Southern Cross Pharma Pty Ltd in 2021 as part of ongoing expansion strategy.
  • Horizon Hospital HealthcareminorStrategic or Co-development Partner · 1 January 2019Acquired a range of injectable products from Horizon Hospital Healthcare in 2019, expanding the hospital portfolio.
  • Goanna BrandcoreStrategic or Co-development Partner · 1 January 2011Acquired marketing rights to the Goanna brand of therapeutic creams, rubs and oils in 2011, a trusted Australian brand with over 100 years of heritage.
  • Max Pharma Pty LtdcoreStrategic or Co-development Partner · 1 January 2009Acquired in 2009, Max Pharma expanded Generic Health's product portfolio to include specialty hospital generics.
  • Bellwether Pharma LtdcoreStrategic or Co-development Partner · 1 January 2007Acquired in 2007, Bellwether Pharma was a supplier of quality generic pharmaceuticals that strengthened Generic Health's early business foundations.
  • Australian Packaging Covenant Organisation (APCO)minorOthersBecame a member of APCO in 2020, committed to working towards achieving the 2025 National Packaging Targets and ensuring packaging materials are reusable, renewable, or recyclable.

Scale indicators4 records

Recent moves6 records

Expansion highlights5 records

Generic Health competitors and assessment

Company assessment

Direct peers

  • Alphapharm (Viatris): Australian generic pharmaceutical subsidiary of Viatris, one of the largest suppliers of prescription generics in Australia. Most direct head-to-head competitor for Generic Health in Australian PBS-reimbursed prescription generics and pharmacy distribution.
  • Apotex: Canadian-headquartered generic pharmaceutical manufacturer with significant Australian operations. Competes directly with Generic Health in the Australian generic prescription market across multiple therapeutic categories distributed through the same pharmacy and hospital channels.
  • Mayne Pharma: Australian specialty pharmaceutical company focused on branded and generic prescription products. Directly comparable as an ANZ-headquartered competitor with overlapping generics and specialty product portfolios targeting similar pharmacy and hospital customers.
  • Arrotex Pharmaceuticals: Australia's largest generic pharmaceutical company by volume, formed via acquisition of multiple local generic businesses. Directly competes with Generic Health in prescription generics and OTC categories across Australian community pharmacy channels.

Regional players

  • Ego Pharmaceuticals: Australian privately-held pharmaceutical company specializing in dermatology and OTC skincare products. Comparable in the ANZ OTC consumer health segment where Generic Health's Pharmacy Action and Goanna brands compete.
  • AFT Pharmaceuticals: Australia and New Zealand-headquartered specialty pharmaceutical company with both OTC and prescription products. Overlaps with Generic Health's OTC portfolio (Pharmacy Action, Goanna) and operates in the same ANZ geographies.

Broad incumbents

  • Viatris: Global pharmaceutical company formed from Mylan-Upjohn combination with substantial generic and specialty portfolio. Competes with Generic Health in Australian prescription generics, specialty injectables, and hospital channel.
  • Teva Pharmaceutical Industries: World's largest generic pharmaceutical manufacturer with operations across most major markets including Australia. Competes broadly with Generic Health across generic prescription categories and specialty products.
  • Sandoz (Novartis): Global generic and biosimilar division of Novartis, one of the largest generic players worldwide. Operates in the Australian generic prescription market as a broad incumbent competing with Generic Health across multiple molecule categories.
  • Cipla Australia: Australian subsidiary of Indian global generic major Cipla. Competes with Generic Health in Australian prescription generics and respiratory/injectable categories, backed by similar parent-company scale economics.

Market position

Strengths4 records

Weaknesses4 records

Competitive moat5 records

Key risks6 records

Key highlights7 records

Customer concentration

Generic Health social profiles

Digital presence

Generic Health financial estimates

Financial estimate

Revenue estimate

Valuation estimate

Generic Health leadership team

Management profile

Number of profiles

Profiles1 record

Generic Health funding detail

Funding detail

Funding overview

Funding rounds

Investors

Funding detail is available on the Subscription and Enterprise plan.Contact sales →

Generic Health M&A and investment

M&A and investment

M&A

Investments

M&A and investment is available on the Subscription and Enterprise plan.Contact sales →

Frequently asked questions about Generic Health

What does Generic Health do?

Generic Health manufactures and supplies high-quality generic prescription medicines, specialty injectable products, and over-the-counter medicines to pharmacies and hospitals across Australia and New Zealand. The portfolio is sold under the Generic Health, Pharmacy Action, Goanna, and Minoxidil brands, with supply into public and private hospitals via dedicated account managers and into community pharmacies through distribution partnerships. The company also conducts in-licensing and out-licensing of pharmaceutical molecules and products with other pharmaceutical firms.

Is Generic Health a public or private company?

Generic Health is a private company. It is classified as corporate owned and is currently operating.

When was Generic Health founded?

Generic Health was founded in 2004. It employs 11 to 50 people.

Where is Generic Health based?

Generic Health is headquartered in Box Hill, Australia, in the Oceania region.

How does Generic Health make money?

Four revenue lines are on record. Prescription Generic Medicines are the primary driver. The others are over-the-Counter Products, hospital Injectable Products and licensing.

Who are Generic Health's main competitors?

Direct peers on record are Alphapharm (Viatris), Apotex, Mayne Pharma and Arrotex Pharmaceuticals. Regional players are Ego Pharmaceuticals and AFT Pharmaceuticals. Broad incumbents are Viatris, Teva Pharmaceutical Industries, Sandoz (Novartis) and Cipla Australia.

Does Generic Health have an API?

No public API is recorded for Generic Health.

What industry is Generic Health in?

Generic Health's product category is Generic Pharmaceuticals. Its primary akta.pro industry code is HLAIABAA, Small-Molecule Generics (Branded/Unbranded), with a secondary code of HLAIABAC, Sterile Injectable Generics. Its NAICS code is 32541 and its SIC code is 2834.

Unlock the full company data

50 free credits on sign-up, no credit card required.

Contact sales